Plasmaderivatives: “Investitori Associati” invests in the sector with a 40% share in leading company Kedrion
Feb 14, 2006 |
CORPORATE
Investitori Associati SGR, the common fund management company for closed-end security investment, is investing in the plasmaderivatives sector with a 40% share in Kedrion SpA, the leading company in Italy in this area. It belongs to the Marcucci family who will retain the majority holding with 60% of the shares. The operation, financed by Banca
First Russian factory plasma-derived products of internal standard to be set up with Kedrion technology
Jan 22, 2006 |
CORPORATE
Kedrion, the leading biopharmaceutical company in the haemoderivatives sector whose principal headquarters is in Tuscany, is to set up a technology exchange in Russia. In 2006, in Kirov in the Volga region, work will begin to set up the first Russian factory producing international standard plasma-derived products. The factory, which will be fully operating by